RGS2 and female common diseases: a guard of women's health

Currently, women around the world are still suffering from various female common diseases with the high incidence, such as ovarian cancer, uterine fibroids and preeclampsia (PE), and some diseases are even with the high mortality rate. As a negative feedback regulator in G Protein-Coupled Receptor signaling (GPCR), the Regulator of G-protein Signaling (RGS) protein family participates in regulating kinds of cell biological functions by destabilizing the enzyme-substrate complex through the transformation of hydrolysis of G Guanosine Triphosphate (GTP). Recent work has indicated that, the Regulator of G-protein Signaling 2 (RGS2), a member belonging to the RGS protein family, is closely associated with the occurrence and development of certain female diseases, providing with the evidence that RGS2 functions in sustaining women's health. In this review paper, we summarize the current knowledge of RGS2 in female common diseases, and also tap and discuss its therapeutic potential by targeting multiple mechanisms.

Automated summary

Currently, women worldwide are still experiencing a high incidence of various common female diseases, such as ovarian cancer, uterine fibroids, and preeclampsia. Recent research suggests that RGS2, a member of the RGS protein family, is closely associated with the occurrence and development of certain female diseases, indicating its potential role in maintaining women's health. This review paper summarizes the current knowledge of RGS2 in female common diseases and explores its therapeutic potential by targeting multiple mechanisms.